Cell Biotech Market Cap

Cell Biotech has a market cap or net worth of 95.34 billion as of February 20, 2026. Its market cap has decreased by -3.60% in one year.

Market Cap

95.34B

Enterprise Value

6.95B

Revenue

50.65B

Ranking

n/a

PE Ratio

7.57

Stock Price

13,970.00

Market Cap Chart

Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 95.34B, an increase of 582.53%. That is a compound annual growth rate of 8.72%.

Market Cap History

Date	Market Cap	% Change
Feb 19, 2026	95.61B	6.56%
Dec 30, 2025	89.72B	-8.13%
Dec 30, 2024	97.66B	27.18%
Dec 28, 2023	76.79B	-11.65%
Dec 29, 2022	86.92B	-34.80%
Dec 30, 2021	133.30B	-19.84%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
TegoScience	113.69B
IMGT Co.,Ltd.	104.97B
CTCBIO	101.61B
KoBioLabs	99.04B
Progen	95.48B
Choong Ang Vaccine Laboratory	92.32B
Naturalendo Tech	92.19B
Shaperon	88.88B

Market Cap Rankings